[Transverse myelitis associated with systemic lupus erythematosus].
Bataller-Peñafiel
E
E
Alcobendas-Maestro
M
M
Flores-Torres
I
I
Esclarín-De Ruz
A
A
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005271:Femur Head Necrosis / Q000209:etiology / Q000534:rehabilitation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D009188:Myelitis, Transverse / Q000188:drug therapy / Q000209:etiology* / Q000534:rehabilitation; D026741:Physical Therapy Modalities; D001750:Urinary Bladder, Neurogenic / Q000209:etiology
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone